Alzheimer’s drug designed for ‘at-home’ use scores FDA breakthrough designation
By
Alicia Lasek
Oct 12, 2021
The experimental Alzheimer’s drug gantenerumab is the “first and only” anti-amyloid antibody being investigated for subcutaneous administration and could potentially be given to patients...
COVID deaths now ‘entirely preventable’ due to vaccines, CDC director says
By
Alicia Lasek
Jun 24, 2021
High vaccine efficacy in the United States means that “every death due to COVID-19 is particularly tragic because nearly every death, especially among adults … [is] entirely preventable,”...
MedDiet cuts diabetes risk by a third in 25-year Women’s Health Study
By
Alicia Lasek
Nov 23, 2020
The Mediterranean diet reduces diabetes risk by 30% in women who are considered clinically overweight or obese, a new analysis of long-term data finds.
Vascular risk factors associated with higher dementia risk as people age
By
John Roszkowski
May 23, 2022
People with vascular conditions such as heart disease, diabetes or high blood pressure have an increased chance of getting dementia as they grow older, a new study has found.
Light exposure during sleep linked to obesity, diabetes, high blood pressure in seniors
Jun 24, 2022
Older men and women who are exposed to any amount of light while sleeping are more likely to have these chronic conditions than their peers who sleep in total darkness, investigators have found.
Eye drop corrects late-life vision loss in trial; Allergan reports patients’ feedback
By
Alicia Lasek
May 10, 2021
Trial participants reported significant near-vision improvements under low-light conditions — without losing distance vision, reports Allergan, which is seeking FDA approval for the drug.
Surgery rates fall in elders; improved screening may be reason
By
Alicia Lasek
May 11, 2021
Despite an aging population and safer surgical procedures, the frequency of abdominal surgery is decreasing among older adults — particularly in those age 85 and older, according to researchers from...
J&J vaccine effective against COVID Delta variant, drugmaker says
By
Alicia Lasek
Jul 06, 2021
Johnson & Johnson’s single-shot COVID-19 vaccine prompts a “strong neutralizing antibody response” that lasts at least eight months, the drugmaker has announced.
Seniors with COPD using more cannabinoids as U.S. interest ‘skyrockets’
By
Alicia Lasek
Sep 30, 2019
Canadian seniors with COPD are using more prescription cannabinoids, while U.S. seniors show a ‘skyrocketing’ interest in the substances for pain relief.
Alzheimer’s cure would mean $16B in lost revenues for assisted living
By
Lois A. Bowers
Sep 17, 2019
A cure for Alzheimer’s disease would be a “medical miracle” but would result in a loss of $16.3 billion in assisted living annual revenues.